Compare Stocks → Move Your Money Before May 22 (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:GNWSDOTCMKTS:GNWSFOTCMKTS:SZLSF Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGNWSDStageZero Life Sciences$0.04$0.03$0.17▼$0.89$1.96M2.974,987 shsN/AGNWSFStageZero Life Sciences$0.04$0.03$0.00▼$1.27$2.52M0.2826,719 shsN/ASZLSFStageZero Life Sciences$0.04$0.03$0.03▼$0.06$4.94M0.6169,038 shsN/AInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGNWSDStageZero Life Sciences+48.15%+2.56%+20.85%+38.89%-36.81%GNWSFStageZero Life Sciences+48.15%+2.56%+20.85%+38.89%-36.81%SZLSFStageZero Life Sciences0.00%+2.56%+20.85%+38.89%-36.81%Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGNWSDStageZero Life SciencesN/AN/AN/AN/AN/AN/AN/AN/AGNWSFStageZero Life SciencesN/AN/AN/AN/AN/AN/AN/AN/ASZLSFStageZero Life SciencesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGNWSDStageZero Life SciencesN/AN/AN/AN/AGNWSFStageZero Life SciencesN/AN/AN/AN/ASZLSFStageZero Life SciencesN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGNWSDStageZero Life Sciences$140K13.98N/AN/A($0.13) per share-0.31GNWSFStageZero Life Sciences$4.15M0.61N/AN/A($0.02) per share-2.00SZLSFStageZero Life Sciences$3.80M1.30N/AN/A($0.07) per share-0.57Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGNWSDStageZero Life Sciences-$3.48MN/A0.00∞N/A217.39%N/A-61.21%N/AGNWSFStageZero Life Sciences-$6.86M-$0.28N/A∞N/A-200.26%N/A-165.13%N/ASZLSFStageZero Life Sciences-$11.41M-$0.12N/A∞N/A-418.64%N/A-1,872.84%N/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGNWSDStageZero Life SciencesN/AN/AN/AN/AN/AGNWSFStageZero Life SciencesN/AN/AN/AN/AN/ASZLSFStageZero Life SciencesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGNWSDStageZero Life SciencesN/A0.090.06GNWSFStageZero Life SciencesN/A1.151.08SZLSFStageZero Life SciencesN/A0.040.03OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGNWSDStageZero Life SciencesN/AGNWSFStageZero Life Sciences0.02%SZLSFStageZero Life SciencesN/AInsider OwnershipCompanyInsider OwnershipGNWSDStageZero Life SciencesN/AGNWSFStageZero Life SciencesN/ASZLSFStageZero Life Sciences2.54%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableGNWSDStageZero Life SciencesN/A48.94 millionN/ANot OptionableGNWSFStageZero Life Sciences5163.00 millionN/ANot OptionableSZLSFStageZero Life Sciences40123.53 million120.40 millionNot OptionableSZLSF, GNWSF, and GNWSD HeadlinesSourceHeadlineStageZero Life Sciences Ltd: StageZero Life Sciences Provides an Update on Application for Management Cease Trade Orderfinanznachrichten.de - April 5 at 12:07 PMStageZero Life Sciences Provides an Update on Application for Management Cease Trade Orderaccesswire.com - April 5 at 7:55 AMStageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Resultsaccesswire.com - April 2 at 9:30 PMStagezero Life Sciences GAAP EPS of -$0.01, revenue of $0.75Mseekingalpha.com - November 15 at 7:45 PMStageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special Meetingfinance.yahoo.com - June 7 at 8:01 PMDually-Listed Healthcare Stock Rallies On Q1 Resultstheglobeandmail.com - May 17 at 4:33 PMStageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023finance.yahoo.com - May 15 at 2:03 PMStagezero Life Sciences GAAP EPS of -$0.09, revenue of $0.7Mmsn.com - April 4 at 12:33 AMStageZero to Issue Q4 2022 Financial Results on Friday March 31finance.yahoo.com - March 30 at 7:51 PMStageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30finance.yahoo.com - March 29 at 7:53 PMResults from METRICs Study Informs Expansion of StageZero's New Care Oncology Protocolfinance.yahoo.com - February 15 at 5:32 PMStageZero Life Sciences Ltd: StageZero Life Sciences Announces Extension of Warrants Expiring in January 2023finanznachrichten.de - January 12 at 7:22 PMStageZero Life Sciences Announces Extension of Warrants Expiring in January 2023finance.yahoo.com - January 12 at 7:22 PMStageZero Life Sciences Ltd. (SZLSF) Q3 2022 Earnings Call Transcriptseekingalpha.com - November 15 at 3:57 PMStageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022finance.yahoo.com - November 12 at 11:34 AMStageZero Life Sciences Ltd: StageZero Announces Solutions for Employers to Help Improve Cancer Outcomesfinanznachrichten.de - August 19 at 11:42 PMStageZero to Hold Q2 2022 Operational and Financial Results Conference Call on Tuesday August 16, 2022finance.yahoo.com - August 12 at 1:45 PMStageZero Life Sciences CFO resignsseekingalpha.com - May 26 at 10:23 AMStageZero Life Sciences Partners with DiagnoseAtHome to Offer Aristotle(R) Multi-Cancer Blood Test in Canada and USAfinance.yahoo.com - May 25 at 7:21 PMStageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational Updatefinanznachrichten.de - May 17 at 8:00 AMStageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational Updatefinance.yahoo.com - May 17 at 8:00 AMStageZero Life Sciences, Ltd Announces Corporate Updatefinance.yahoo.com - April 6 at 5:36 PMStageZero Life Sciences, Ltd Announces Q4 2021 and Year End Financial Results and Operational Updatefinance.yahoo.com - April 1 at 8:29 AMStageZero Life Sciences Ltd: StageZero Life Sciences Launches AVRT in the UKfinanznachrichten.de - March 31 at 10:29 PMMedia Sentiment Over TimeCompany DescriptionsStageZero Life SciencesOTCMKTS:GNWSDStageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall in 1998 and is headquartered in Markham, Canada.StageZero Life SciencesOTCMKTS:GNWSFStageZero Life Sciences Ltd. develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. It also offers Aristotle, a multi-cancer panel test for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer; and COVID PCR testing and blood test analysis. StageZero Life Sciences Ltd. is headquartered in Richmond Hill, Canada.StageZero Life SciencesOTCMKTS:SZLSFStageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer panel test for for the detection of multiple discrete cancers from a single sample of blood. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; Prostate Health Index, a screening test for prostate cancer; BreastSentry, a test to determine a woman's risk for developing breast cancer; and COVID-19 Tests. The company is based in Richmond Hill, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.